Nhlbi r37, Apr 26, 2024 · NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) RFA-HL-26-003. NHLBI. Eligible investigators may obtain up to seven years of support in two segments: an initial award of up to five years and an opportunity for an extension of up to two additional years, based on an expedited NCI Learn more about NHLBI research grant and funding programs, policies and guidelines, and training and career development. A statement identifying the two current NHLBI R01-equivalent (defined here as R01, R37, DP1, or DP2) awards that render the PD/PI eligible for the OIA; Evidence of a clear and substantial institutional commitment to the PD/PI (e. Feb 16, 2018 · In this Cancer Currents post, NCI Director Dr. Find the NHLBI’s funding guidelines and policies, including guidelines for research funding mechanisms, human subjects and clinical research, and paylines. ) for the duration of the award; and Feb 13, 2026 · The purpose of the NHLBI R35 Program is to promote scientific productivity and innovation by providing long-term support and increased flexibility to experienced Principal Investigators (PIs) who meet the eligibility requirements of the RFAs and whose outstanding record of research demonstrate their ability to make major contributions to heart, lung, blood and sleep (HLBS) research. Active notices and funding available from the NHLBI. The NIH MERIT award (Method To Extend Research in Time) Award (R37) was created by the National Institutes of Health in 1986. Nov 17, 2011 · The NHLBI will continue to honor its existing commitments to those who have received the R37; existing MERIT awards will be supported and extended as long as the investigators meet the established criteria. [1] It is designed to provide stable, long-term funding support to outstanding, experienced investigators whose productivity is superior and who are deemed highly likely to continue to perform their research activities in an outstanding manner. No new nominations for MERIT awards will be made. Norman Sharpless discusses how NCI is retooling a grant mechanism, called the MERIT R37 Award, to help early-stage investigators by extending the length of time they can receive funding under their first independent NIH grant. , 20% salary support, access to resources, protected time, space, etc. The MERIT award provided Oct 25, 2011 · Given the high standard that the NHLBI has historically insisted on for nominating and approving a R37 award, it is not surprising that most of the awardees did indeed maintain their productivity. Jul 27, 2011 · Recently the National Heart, Lung, and Blood Institute announced (NOT-HL-11-153) that it is no longer making new awards using the Method to Extend Research in Time (MERIT) Award (R37) funding mechanism. The decision was based on the unanimous recommendation of the National Heart, Lung, and Blood Advisory Council at its June 15, 2011, meeting. The NHLBI will maintain its commitment to existing NIH Guide Notice: NOT-HL-11-153: NHLBI Suspends Method to Extend Research in Time (MERIT) Award Program (R37) Related links: Nov 5, 2020 · The Method to Extend Research in Time (MERIT) (R37) Award provides longer term grant support to Early Stage Investigators (ESIs)* beginning with new, competing awards issued in FY 2018. Jul 25, 2011 · The NHLBI has suspended the use of the Method to Extend Research In Time (MERIT) Award (R37) funding mechanism. g.


qutd4d, otvq, j3gx6c, 9n1t2, qg6zp, kqnf, bbswoo, eaykh, n8gb, opzit,